On Monday, Caredx Inc (NASDAQ: CDNA) opened higher 4.24% from the last session, before settling in for the closing price of $23.13. Price fluctuations for CDNA have ranged from $7.42 to $34.84 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 33.42%. Company’s average yearly earnings per share was noted 80.23% at the time writing. With a float of $50.16 million, this company’s outstanding shares have now reached $51.50 million.
Let’s determine the extent of company efficiency that accounts for 643 employees. In terms of profitability, gross margin is 65.16%, operating margin of -18.45%, and the pretax margin is -45.8%.
Caredx Inc (CDNA) Insider Activity
A key investor’s attitude towards the stock of the Diagnostics & Research industry is another important factor to consider. The insider ownership of Caredx Inc is 6.48%, while institutional ownership is 97.23%. The most recent insider transaction that took place on Nov 25 ’24, was worth 28,288. Before that another transaction happened on Nov 18 ’24, when Company’s Officer proposed sale 5,534 for $21.17, making the entire transaction worth $117,155.
Caredx Inc (CDNA) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.17 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.27) by 0.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 80.23% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.00% during the next five years compared to -21.96% drop over the previous five years of trading.
Caredx Inc (NASDAQ: CDNA) Trading Performance Indicators
Check out the current performance indicators for Caredx Inc (CDNA). In the past quarter, the stock posted a quick ratio of 3.87. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.24. Likewise, its price to free cash flow for the trailing twelve months is 1085.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.70, a number that is poised to hit -0.21 in the next quarter and is forecasted to reach -0.53 in one year’s time.
Technical Analysis of Caredx Inc (CDNA)
Looking closely at Caredx Inc (NASDAQ: CDNA), its last 5-days average volume was 0.72 million, which is a drop from its year-to-date volume of 0.9 million. As of the previous 9 days, the stock’s Stochastic %D was 64.38%. Additionally, its Average True Range was 1.36.
During the past 100 days, Caredx Inc’s (CDNA) raw stochastic average was set at 48.29%, which indicates a significant decrease from 79.64% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 38.95% in the past 14 days, which was lower than the 74.11% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $25.94, while its 200-day Moving Average is $18.42. However, in the short run, Caredx Inc’s stock first resistance to watch stands at $24.66. Second resistance stands at $25.20. The third major resistance level sits at $26.04. If the price goes on to break the first support level at $23.28, it is likely to go to the next support level at $22.44. Should the price break the second support level, the third support level stands at $21.90.
Caredx Inc (NASDAQ: CDNA) Key Stats
There are currently 53,634K shares outstanding in the company with a market cap of 1.32 billion. Presently, the company’s annual sales total 280,320 K according to its annual income of -190,280 K. Last quarter, the company’s sales amounted to 82,880 K and its income totaled -7,410 K.
